GlobeNewswire by notified

Savosolar Plc – Managers’ Transaction, Jussi Mälkiä, December 2022

Share

Savosolar Plc
Company Announcement            8 March 2023 at 8.30 a.m. (CET)



Savo
solar Plc – Managers’ Transaction, Jussi Mälkiä, December 2022



Person subject to the notification requirement
Name: Jussi Mälkiä
Position Member of the Board/Deputy member
Initial Notification
Reference number: 26713/5/4
Issuer
Name: Savosolar Oyj
LEI: 743700J1YZ8IEJAPDL21
Transaction details
Transaction date: 2022-12-29
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Nature of the transaction: DISPOSAL
Further details:
Instrument: Share
ISIN: FI4000425848
Volume: 2580645
Unit price: 0.07750 Euro
Aggregated transactions
Volume: 2580645
Volume weighted average price:

0.07750 Euro

SAVOSOLAR PLC

For more information:

Savosolar Plc
Managing Director Jari Varjotie
Phone: +358 400 419 734
E-mail: jari.varjotie@savosolar.com



Savosolar in brief
Savosolar has two business areas: Marine Logistics and Renewable Energy.


Marine Logistics (Meriaura Oy) is a major provider of transport for bulk cargo and demanding project deliveries in Northern Europe, especially in the Baltic Sea and North Sea regions. The company provides its customers with competitive and environmentally sustainable marine transport services, which also reduce carbon emissions from marine transport. Its long-term affreightment agreements, modern fleet and strong market position in renewable energy construction projects enable freight that supports environmentally friendly solutions. As part of Marine Logistics, VG-EcoFuel Oy produces recycled biofuels from bio-oils and recycled oils generated as industrial by-products.


The Renewable Energy (Savosolar Oyj) designs and delivers clean energy production systems as comprehensive deliveries. The systems are built around large-scale solar thermal systems implemented using high-performance solar heat collectors manufactured by the company. Other energy production and storage technologies can also be combined with the systems. The company has taken solar thermal technology to a new level, and its collectors have patented nano-coated direct flow absorbers. With this leading technology, Savosolar enables its customers to produce clean and competitive energy.

Savosolar’s shares are listed on Nasdaq First North Growth Market Sweden under the ticker symbol SAVOS and on Nasdaq First North Growth Market Finland under the ticker symbol SAVOH. www.savosolar.com.


The company’s Certified Adviser is Augment Partners AB, info@augment.se, tel. +46 8-604 22 55.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Prepayments, Realkredit Danmark A/S6.5.2024 11:12:01 CEST | Press release

To Nasdaq Copenhagen A/SExecutive Management Bernstorffsgade 40 DK-1577 København V www.rd.dk Telephone +45 7012 5300 6 May 2024 Company Announcement No 34/2024 Prepayments, Realkredit Danmark A/S Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes prepayments as of Friday 3 May 2024. Please find the data in the attached file. The information will also be available on www.rd.dk. Yours sincerely The Executive Management Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068. Attachments Nr 34_Ekstraordinaere indfrielser_ukBilag til selskabsmeddelelse nr 34-2024

Ekstraordinære indfrielser, Realkredit Danmark A/S6.5.2024 11:12:01 CEST | pressemeddelelse

Til Nasdaq Copenhagen A/SDirektionen Bernstorffsgade 40 1577 København V www.rd.dk Telefon 7012 5300 6. maj 2024 Selskabsmeddelelse nummer 34/2024 Ekstraordinære indfrielser, Realkredit Danmark A/S I medfør af lov om kapitalmarkeder §24 oplyses hermed om ekstraordinære indfrielser vedrørende Realkredit Danmark A/S pr. fredag den 3. maj 2024. Oplysningerne fremgår af vedhæftede datafil. Oplysningerne vil desuden kunne ses på Realkredit Danmarks hjemmeside på www.rd.dk. For yderligere informationer om dataformat og –indhold henvises til Nasdaq Copenhagen A/S’s hjemmeside. Med venlig hilsen Direktionen Eventuel henvendelse kan rettes til chefanalytiker Hella Gebhardt Rønnebæk, 45 13 20 68. Vedhæftede filer Nr. 34_Ekstraordinaere indfrielser_dkBilag til selskabsmeddelelse nr 34-2024

Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia6.5.2024 11:00:00 CEST | Press release

Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well tolerated following intravitreal administration of single and multiple doses, meeting its primary safety endpoints and showed early signs of potential efficacy.1­ DMI is a common, irreversible complication of diabetic retinopathy (DR) that may lead to blindness.12,3,4­ It can develop when the light sensitive tissues of the central retina do not receive adequate blood supply over a longer time. There are currently no approved treatments for DMI. The current standard of care for advanced DR includes intravitreal anti-VEGF treatment or invasive laser treatment. However, some patients’ conditions progress despite this treatment.5 BI 764524 uses a novel mode of action by inhibiting the Sema3A pathway to re-vascularize ischemic areas and potentia

Orion Corporation: Managers’ transactions – Eija Ronkainen6.5.2024 11:00:00 CEST | Press release

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST Orion Corporation: Managers’ transactions – Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Eija Ronkainen Position: Member of the Board/Deputy member Issuer: Orion Oyj LEI: 74370029VAHCXDR7B745 Notification type: INITIAL NOTIFICATION Reference number: 61636/4/4 ____________________________________________ Transaction date: 2024-05-03 Outside a trading venue Instrument type: SHARE ISIN: FI0009014377 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume: 556 Unit price: 0 EUR Aggregated transactions (1): Volume: 556 Volume weighted average price: 0 EUR Ori

Orion Corporation: Managers’ transactions – Henrik Stenqvist6.5.2024 11:00:00 CEST | Press release

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST Orion Corporation: Managers’ transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Henrik Stenqvist Position: Member of the Board/Deputy member Issuer: Orion Oyj LEI: 74370029VAHCXDR7B745 Notification type: INITIAL NOTIFICATION Reference number: 61645/4/4 ____________________________________________ Transaction date: 2024-05-03 Outside a trading venue Instrument type: SHARE ISIN: FI0009014377 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume: 556 Unit price: 0 EUR Aggregated transactions (1): Volume: 556 Volume weighted average price: 0 EUR

HiddenA line styled icon from Orion Icon Library.Eye